Filing Flows › Ocugen (OCGN) › Q2 2025
Ocugen (OCGN) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 4, 2025
Ocugen (OCGN) reported revenue of $1.4M for the second quarter 2025 (Q2 2025), +20% from a year earlier and -7% from the quarter before.
Ocugen, Q2 2025: revenue $1.4M (+20% year over year), net loss $14.7M, operating cash flow −$10.7M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.4M | -7% | +20% |
| Operating profit | −$13.8M | — | — |
| Net earnings | −$14.7M | — | — |
| Operating cash flow | −$10.7M | — | — |
What changed
Revenue was $1.4M in Q2 2025, up 20% year over year and down 7% from the previous quarter.
Operating costs exceeded revenue by $13.8M, an operating margin of -1004.7%. Total costs fell 9% while revenue rose 20%. The quarter ended with a net loss of $14.7M, narrower than the previous quarter's $15.3M loss.
Operating cash flow was −$10.7M. Non-cash charges added back $600K of depreciation and $1.8M of share-based compensation. Working capital and other items added $1.6M. Capital expenditures of $43K exceeded it, leaving free cash flow of −$10.8M.
Questions
What was Ocugen's revenue in the second quarter 2025?
Ocugen (OCGN) reported revenue of $1.4M for the second quarter 2025 (Q2 2025), +20% from a year earlier and -7% from the quarter before.
Source: Ocugen 10-Q on SEC EDGAR.